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Background: Low back pain (LBP) patients with related leg pain have a more severe profile than those with local
LBP and a worse prognosis. Pain location above or below the knee and the presence of neurological signs
differentiate patients with different profiles, but knowledge about the prognostic value of these subgroups is
sparse. The objectives of this study were (1) to investigate whether subgroups consisting of patients with Local LBP
only, LBP + leg pain above the knee, LBP + leg pain below the knee, and LBP + leg pain and neurological signs had
different prognoses, and (2) to determine if this was explained by measured baseline factors.
Methods: Routine clinical data were collected during the first visit to an outpatient department and follow-ups
were performed after 3 and 12 months. Patients were divided into the four subgroups and associations between
subgroups and the outcomes of activity limitation, global perceived effect (GPE) after 3 months, and sick leave after
3 months were tested by means of generalised estimating equations. Models were univariate (I), adjusted for
duration (II), and adjusted for all baseline differences (III).
Results: A total of 1,752 patients were included, with a 76% 3-month and 70% 12-month follow-up. Subgroups
were associated with activity limitation in all models (p < 0.001). Local LBP had the least and LBP + neurological signs
the most severe limitations at all time-points, although patients with neurological signs improved the most.
Associations with GPE after 3 months were only significant in Model I. Subgroups were associated with sick leave
after 3 months in model I and II, with sick leave being most frequent in the subgroup with neurological signs. No
significant differences were found in any pairwise comparisons of patients with leg pain above or below the knee.
Conclusions: Subgrouping LBP patients, based on pain location and neurological signs, was associated with activity
limitation and sick leave, but not with GPE. The presence of neurological signs and pain in the leg both have
prognostic implications but whether that leg pain without neurological signs is above or below the knee does not.
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It is widely believed that the identification of homoge-
neous subgroups of low back pain (LBP) patients is im-
portant for the optimal prediction of prognosis and care
[1,2]. LBP patients with leg pain are reported to differ
from those with local LBP only, both in terms of general
clinical characteristics and prognosis. However, patients
with leg pain do not form a single homogenous group* Correspondence: a.kongsted@nikkb.dk
Research Department, The Spine Centre of Southern Denmark, Middelfart,
Hospital Lillebaelt, Institute of Regional Health Services Research, University
of Southern Denmark, Part of Clinical Locomotion Network, Ostre Houghvej
55, Middelfart 5500, Denmark
© 2013 Kongsted et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orand the association between leg pain and prognosis is
quite weak [3-5]. More detailed examination of sub-
groups within the leg pain population [6,7] may lead to
identification of stronger prognostic indicators.
LBP-related leg pain has been subgrouped into pain
above the knee, pain below the knee and leg pain with
neurological signs [6]. Classifying patients into these
three subgroups and patients with local LBP only, as de-
scribed by the Quebec Task Force on spinal pain (QTF),
has shown associated differences on a number of clinical
characteristics that display a generally increasing severity
from patients with local LBP, across the categories of legral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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neurological signs [8-10]. These subgroups have also
been demonstrated to differ on the outcomes of pain
and activity limitation in one study involving a clinical
population [11], and on pain, activity limitation and
work loss in a study conducted in a workplace setting
[12]. These studies did not investigate the extent to
which the predictive value of subgrouping was explained
by differences in baseline characteristics. In two studies
from primary care comparing outcomes on physical and
psychological symptoms between the subgroups of local
LBP, LBP with leg pain above the knee, and LBP with leg
pain below the knee, patients with leg pain below the
knee had the worst outcomes [13,14]. Other baseline
factors accounted for most of the differences observed
between subgroups in one of these studies [13], but not
in the other [14].
Differentiation between leg pain above and below the
knee and leg pain with and without neurological signs
were suggested as diagnostic tools more than twenty
years ago [6], but still there is sparse knowledge about
their clinical relevance for prognosis or as treatment
effect moderators. A recent systematic review of the im-
pact of LBP-related leg pain on outcomes concluded that
leg pain appears to be associated with worse outcomes,
but highlighted the lack of evidence concerning leg pain
subgroups [15]. Furthermore, the reviewed studies did
not allow the authors to assess whether the presence of
leg pain was an independent predictor of outcome.
The objective of the current study was to investigate
whether the four QTF subgroups were associated with
activity limitation after 3 and 12 months, global per-
ceived effect after 3 months, or sick leave at 3 months
follow-up in patients referred to a secondary care out-
patient department, and whether observed associations
could be explained by differences in measured baseline
characteristics.
Methods
The setting and baseline data collection have been previ-
ously reported in full detail [8]. In short, data collection
was part of the daily clinical routine in a secondary care
outpatient department seeing approximately 9,000 new
spinal pain patients per year. At the first visit to the de-
partment, patients completed a questionnaire on a touch
screen in the waiting area prior to seeing a clinician. Clini-
cians entered the results of a core set of clinical variables
when examining the patient or following the consultation.
Both patient-reported and clinician-reported data were
entered directly into the Department’s electronic registry,
the SpineData database (Regional Ethics Committee Pro-
ject ID S-200112000-29). Patients were invited to com-
plete a follow-up questionnaire after 3 and 12 months
either electronically or in paper format. Only patients whogave informed consent for their data to be used for scien-
tific purposes were included in the study.Study sample
All patients aged 18 years or older who were referred
with LBP as their main complaint and were seen in the
Department between 10 October 2010 and 30 November
2011 were potential participants. Additional inclusion
criteria were that data needed to be available from pain
intensity scales, a pain drawing, and from the clinician’s
neurological examination in SpineData.Baseline characteristics
Baseline factors were chosen from the health domains of
pain, activity limitation, psychology and work participa-
tion on the basis of their having evidence of a prognostic
association with LBP [3,8].
Pain items were: duration (months), previous LBP epi-
sodes (yes/no), LBP intensity (averaged 0–10 Numerical
Rating Scales (NRS) on present LBP, worst LBP last
14 days and typical LBP last 14 days [16]), intensity of leg
pain (measured in the same way as for LBP), and pain
irritability (requiring a yes-answer to both ’pain is easily
aggravated by physical activity’ and ’it takes a long time
before it settles again’ [17,18]).
Activity limitation was measured with the 23-item
Roland Morris Disability Questionnaire (RMDQ) [19] and
calculated as a proportional score (0% = no activity limita-
tion; 100% =maximum activity limitation) [20].
Work participation was assessed as days on sick leave
(days off work during the preceding 3 months due to LBP
among patients who had conventional employment - were
not unemployed, a student, retired or receiving a pension).
Depressive symptoms were measured by the two
PRIME-MD 1000 screening questions [21] using a 0–10
NRS (proportion of patients with a score above 6 on
both questions). These cut-points were derived in our
setting (unpublished data) based on a comparison with
population-based thresholds for the Beck Depression
Index [22] and the Major Depression Inventory [23].
Pain-related fear of movement was measured using NRS
0–10 scales (proportion with a total score on two
screening questions from the Fear Avoidance Belief
Questionnaire equal to or above 14) [24]. This threshold
was also derived in an unpublished study in our patient
setting based on a comparison with a primary care score
threshold (mean plus 1 standard deviation) on the
physical activity subscale of the Fear Avoidance Belief
Questionnaire.
General health was evaluated using the Euroqol health
thermometer (Euroqol VAS) that measures self-reported
health status today (0 = worst imaginable; 100 = best
imaginable) [25].
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The four subgroups were formed using the following
definitions.
Local LBP only: The pain drawing only included local
LBP, and the worst leg pain intensity in the preceding
14 days was zero (0–10 scale).
LBP + pain above knee: The pain drawing included
pain in the anterior or posterior thigh but no pain in the
calf or feet, and the worst leg pain intensity in the last
14 days was one or more (0–10 scale).
LBP + pain below knee: The pain drawing indicated
pain in the calf and/or foot and the worst leg pain inten-
sity in the last 14 days was at least one.
LBP with signs of nerve root involvement (LBP + NRI):
The pain drawing included pain below the gluteal folds
or the groin, worst leg pain intensity was one or more,
and at least one of the following findings was present on
the painful side during the clinical examination: muscle
weakness, impaired tendon reflexes, altered sensation to
touch or pinprick, a straight leg raise test that provoked
their familiar leg pain (at 60 degrees or less as judged
visually), or a positive prone knee bend test combined
with pain to the anterior thigh (Reverse Laségue Test).
The term ‘signs of nerve root involvement’ should be
considered a label given to patients fulfilling these cri-
teria rather than a definitive diagnostic entity.
If classification was unclear, for example a patient
reporting leg pain intensity to be zero but indicating leg
pain on the pain drawing, the patient was excluded from
the analysis. Such ambiguous reporting was not neces-
sarily due to inaccurate answers since the intensity scale
asked about the last 14 days, whereas patients were
asked to indicate ‘where your pain is’ in the pain chart.
Outcome measures
Activity limitation was measured after 3 and 12 months
by the RMDQ and converted to a proportional score [20].
Global perceived effect was scored on a 7-point Likert
scale (‘much worse’ to ‘much better’) at 3-month follow-
up. This was not repeated after 12 months since self-
assessment of effects that are based on recall seem to be
problematic if asked about longer-term changes [26].
Sick leave was defined as the proportion of those in
the working population at baseline (that is, not un-
employed, a student, a housewife, retired or receiving a
pension) who reported being on sick leave due to LBP at
the time of the 3-month follow-up. Data on sick leave
were not available at 12 months.
Data analyses
Baseline characteristics were presented as proportions with
95% confidence intervals (95% CI), means with standard
deviations (SD), or medians with interquartile ranges (IQR)
depending on the data distribution of the variable.An association between subgroup and activity limitation
was primarily tested in a longitudinal model using popu-
lation averaged generalised estimating equations (GEE)
(family Gaussian, link identity, correlation structure ex-
changeable) which take into account that measures of ac-
tivity limitation were repeated. The subgroup variable was
introduced as a categorical variable in the analysis with
dummy variables that had local LBP only as the reference
category. In addition, absolute subgroup differences at
each follow-up time point were tested for statistical sig-
nificance in generalized linear models. The associations
with global perceived effect and sick leave were tested by
means of GEE (family binomial, link function logit). ‘Suc-
cess’ on global perceived effect being defined as ‘much
better’ or ‘better’ and all other categories as ‘failure’.
Associations are presented as unadjusted β-values/Odds
ratios with 95% CI (Model I). In addition, estimates ad-
justed for duration of LBP at the first visit (Model II), and
adjusted for duration and factors differing between sub-
groups at baseline (Model III) were calculated. Only co-
variates with p < 0.1 were kept in Model III with global
perceived effect and sick leave as the outcomes because
the number of cases was too low to allow for a larger
model. Missing values on baseline variables used as covar-
iates were imputed using multiple imputations by five
chained iterations (logit for binary, mlogit for categorical,
and predictive mean matching for continuous variables).
Seventy-five per cent of patients had no missing data, and
most imputed variables had less than 10% imputed data.
However, 17% were imputed for pain irritability and 10%
for self-reported general health.
Model I was mainly considered relevant to the setting
of the study, since differences in duration between sub-
groups were regarded to be a consequence of referral
patterns to the Department rather than related to the
condition. Model II answered whether the four QTF sub-
groups were associated with outcome, and Model III in-
vestigated whether an observed association could be
explained by differences in measured baseline characte-
ristics. Episode duration was categorised by being split
into 25% quartiles since it had a non-linear relationship
with the outcome measures.
All analyses were performed using STATA/SE 12.1




A total of 2,652 LBP patients above 18 years of age were
registered in SpineData within the inclusion period of the
study (56% females, mean age 50 years). From these 2,405
fulfilled the inclusion criteria and 1,752 (55% females,
mean age 50 years) could be classified in the pre-defined
subgroups (Figure 1).
Figure 1 Flow chart from registration in clinical registry to 12-month follow-up. * Proportion of working population responding to the sick
leave question.
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than one neurological sign. Of those with only one sign,
73 patients had only a positive straight leg raise, 45 had
only reduced muscle strength, 135 had only altered sen-
sation, and 18 had only impaired tendon reflexes.
Follow-up after 3 and 12 months was completed by
76% and 70% respectively, but response rates relating to
sick leave were lower (Figure 1). Non-responders did not
differ significantly from responders on LBP intensity,
duration, activity limitation, depression or fear of move-
ment at baseline. However, non-responders at 3-months
follow-up were more often male (48% vs. 43%) and were
on average 1.4 years younger as compared with the re-
sponders (p < .05). These differences between responders
and non-responders did not differ significantly between
subgroups. Non-responders at 12-month follow-up were
on average 3.3 years younger (p < .05), and did not differ
significantly from responders on other baseline factors.
Also, non-response to the sick leave question did not
differ across subgroups.
Baseline characteristics
Patient self-reported characteristics are summarised in
Table 1. Statistically significant differences across sub-
groups were observed for all measured baseline factors
except fear of movement. Generally, those with Local LBP
were the least severely affected and those with LBP +NRI
had the most severe profile. The differences observed induration indicated that patients with LBP +NRI were re-
ferred to the Department earlier than other patients, but
even in that subgroup, many patients reported very long-
lasting pain.
Associations between subgroups and activity limitation
Activity limitation from baseline to 12-month follow-up
within the four subgroups is illustrated in Figure 2. Sta-
tistically significant associations were present between
subgroups on change in activity limitation in both the un-
adjusted and adjusted analyses (Table 2). However, the re-
sidual variance was only slightly reduced by subgroups
(R2 = .04). Patients with LBP +NRI improved more than
other subgroups in pairwise comparisons, and the esti-
mated effect of being in the LBP +NRI subgroup on the
course of activity limitation was largely unaltered after
adjusting for duration and other covariates.
Looking at absolute RMDQ scores, the subgroup with
Local LBP had the least activity limitation at all time
points and the LBP +NRI the most (Figure 2). Pairwise
comparisons of absolute RMDQ scores adjusted for du-
ration (Model II) were all significant (p < 0.05) except that
LBP + pain above knee and LBP + pain below knee did not
differ significantly at any time point. In Model III, LBP +
NRI differed significantly from Local LBP at 3-month fol-
low-up. At 12-month follow-up, significant differences
existed between Local LBP and LBP + pain above knee
and between Local LBP and LBP +NRI. However a very











For test of any differences
across all subgroups
Females, (95% CI) 50% (44–56) 60% (54–67) 61% (56–67) 54% (50–57) 0.01
Age in years, median (IQR) 47 (36–58) 45 (36–56) 52 (40–66) 50 (38–62) <0.001
Duration in months, median (IQR) 16 (6–57) 14 (6–38) 12 (5–47) 7 (3–26) <0.001
Previous episodes, (95% CI) 69% (64–75) 77% (71–83) 74% (69–79) 79% (76–81) 0.02
Pain irritability, (95% CI) 61% (55–68) 73% (66–80) 69% (63–74) 76% (73–80) <0.001
LBP intensity, median (IQR) 5 (4–7) 6 (4–7) 6 (4–7) 6 (5–8) <0.001
Leg pain intensity, median (IQR) 0 4 (3–6) 6 (4–7) 6 (5–8) <0.001 (local LBP not in test)
Activity limitation, median (IQR) 48 (26–66) 57 (39–73) 61 (43–74) 70 (57–83) <0.001
Any sick leave days in last 3 months*, (95% CI) 42% (34–51) 48% (37–59) 46% (37–55) 55% (50–60) 0.04
Depressive symptoms, (95% CI) 12% (8–16) 17% (12–22) 13% (10–17) 20% (18–23) 0.002
Fear of movement, (95% CI) 21% (16–26) 24% (18–29) 20% (16–24) 26% (23–29) 0.09
General health, mean (SD) 56 (24) 53 (22) 50 (23) 50 (23) <0.001
* among those in conventional employment n = 1,002.
Figure 2 Mean RMDQ scores in four subgroups at baseline, 3 months, and 12 months. Activity limitation in four subgroups at the initial
visit to the Department and over the clinical course.
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Table 2 Associations between subgroups and activity
limitations (Roland Morris Disability Questionnaire




























7.5 (2.8 – 12.2)* 8.0 (3.4 – 12.7)* 2.2 (−2.4 – 6.7)
LBP + pain
below knee
9.3 (5.2 – 13.5)* 9.7 (5.6 – 13.8)* 3.4 (−0.9 – 7.8)
LBP + NRI 19.8 (16.2 – 23.3)*¤ § 21.0 (17.5 – 24.5)*¤§ 11.3 (7.1 – 15.4)*¤§





−0.2 (−5.1 – 4.7) −0.2 (−5.1 – 4.7) 0.0 (−4.9 – 4.9)
LBP + pain
below knee
−0.3 (−4.6 – 4.0) −0.4 (−4.6 – 3.9) −0.2 (−4.5 – 4.1)
LBP+NRI −6.7 (−10.4 – -3.1)*¤ § −6.4 (−10.0 – -2.4)*¤§ −6.3 (−10.0 – -2.7)*¤§





2.1 (−2.9 – 7.1) 2.2 (−2.8 – 7.1) 2.2 (−2.7 – 7.2)
LBP + pain
below knee
−1.0 (−5.4 – 3.5) −0.9 (−5.3 – 3.5) −1.0 (−5.4 – 3.4)
LBP +NRI −6.3 (−10.1 – -2.5)*¤§ −6.2 (−10.0 – -2.4)*¤§ −6.3 (−10.0 – -2.5)*¤§
Subgroup effect and Subgroup X Time effects: p < 0.001 in all Models I-III;
*p < 0.05 in comparison with Local LBP; ¤ p < 0.05 in comparison with LBP +
pain above knee; §p < 0.05 in comparison with LBP + pain below knee.
Table 3 Associations between subgroups and general















1.13 (0.70 – 1.82) 1.06 (0.64 – 1.76)
LBP + pain
below knee
0.85 (0.55 – 1.31) 0.76 (0.48 – 1.20)
LBP + NRI 1.58 (1.11 – 2.26)*§ 1.12 (0.77 – 1.64)
AUC = 0.57
Odds ratios for being ‘much better’ or ‘better’ after 3-months.
*p < 0.05 in comparison with Local LBP.
§p < 0.05 in comparison with LBP + pain below knee.
AUC Area under the Receiver Operating Characteristic curve.
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explained by subgroups (R2 = .02 for 3- and 12-month
analyses).
Associations between subgroups and global perceived effect
At the 3-month follow-up, 31% of the cohort reported
to be ‘much better’ or ‘better’. This proportion varied
across the subgroups from 23% in the LBP + pain below
knee subgroup to 36% in the LBP + NRI subgroup. There
were statistically significant associations between the
subgroups and global perceived effect in Model I but the
prognostic capacity in terms of AUC was low, and the
association was not significant when duration was takeninto account in Model II (Table 3). Therefore Model III
was considered irrelevant. The LBP + NRI subgroup had
higher odds of being ‘much better’ or ‘better’ as com-
pared with the Local LBP and the LBP + pain below knee
subgroups in pairwise comparisons (Table 3).
Associations between subgroups and sick leave
At baseline 1,003 (57%) of the participating patients were
in the working population (Local LBP only 64%, LBP +
above knee 62%, LBP + below knee 54%, and LBP +NRI
56%. P = 0.03). At the 3-months follow-up 29% (95% CI:
25-33%) of these were currently on sick leave, with the
distribution in the subgroups ranging from 19% in the
Local LBP subgroup to 35% in the LBP +NRI subgroup
(p = 0.02). A larger proportion of patients in the LBP +
NRI subgroup were on sick leave at 3 months and sub-
groups were significantly associated with sick leave in
model I and model II but not in model III (Table 4).
Discussion
This study investigated whether subgrouping of LBP pa-
tients based on leg pain patterns had any prognostic im-
plications. Patients with LBP +NRI improved more than
other subgroups on change in activity limitation but had a
poorer outcome as measured by absolute RMDQ scores
after one year. Patients with Local LBP, LBP + pain above
knee, and LBP + pain below knee all had similar trajecto-
ries of activity limitation. This resulted in similar absolute
RMDQ scores for LBP + pain above knee and LBP + pain
below knee patients. In contrast, the Local LBP was the
subgroup least affected by activity limitation both at base-
line and after one year.
There was no significant association between subgroups
and global perceived effect above that which could be
explained by differences in duration. For the outcome of sick
Table 4 Sick leave among the working population in each

























1.44 (0.64 – 3.26) 1.45 (0.64 – 3.28) 1.21 (0.50 – 2.91)
LBP + pain
below knee
1.23 (0.57 – 2.63) 1.18 (0.55 – 2.54) 0.84 (0.37 – 1.91)
LBP + NRI 2.25 (1.21 – 4.19)*§ 2.13 (1.13 – 4.00)*§ 1.21 (0.61 – 2.43)
AUC = 0.58 AUC = 0.60
*p < 0.05 in comparison with Local LBP.
§p < 0.05 in comparison with LBP + pain below knee.
AUC Area under the Receiver Operating Characteristic curve.
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of long-lasting sick leave at 3 months compared with patients
in the Local LBP and LBP+ pain above knee subgroups.
The larger improvement in activity limitation within
the LBP + NRI group was not explained by other mea-
sured baseline factors. Duration, age, gender, previous
LBP episodes, pain irritability, LBP intensity, leg pain in-
tensity, depression, and general health were all taken
into account but differences on these factors between
subgroups were not shown to be the reason for the dif-
ferent trajectories. Thus, the presence of neurological
signs was associated with larger improvement, but at the
same time a poorer outcome, and this is likely to be a
direct effect of nerve root involvement. The finding that
patients with neurological signs report better global per-
ceived effect and poorer absolute outcome has been ob-
served in previous studies that used unadjusted analyses.
Those studies included patients from surgical depart-
ments [11] and a workplace setting [11,12]. In a primary
care cohort, which predictably had a shorter LBP dur-
ation than our secondary care cohort, Hill et al. [13]
found that prognostic differences between subgroups
with local LBP, LBP + pain above knee, and LBP + pain
below knee were explained by other baseline characteris-
tics. It may be that such baseline characteristics are im-
portant covariates early in the clinical course but our
results highlight that the inclusion of neurological signs
is more prognostically important than only distinguishing
between pain above and below the knee, and we believe
presence of the LBP + NRI subgroup is likely to be a cen-
tral explanation for why our results differ from those of
Hill et al.A strength of the current study is that data were col-
lected prospectively from a near-complete cohort of
people in routine care. We believe this strengthens the
generalisability of our results to other chronic LBP popu-
lations. Furthermore, the sample size was adequate for the
conducted analyses, and data were available that made
possible analyses of outcomes across different domains of
health. Lastly, the response rates of 76% and 70% at the
two follow-up time points, that were very similar in all the
studied subgroups, we consider to be acceptable for a clin-
ical registry.
The study also had limitations. The most important
limitation from our perspective was the definition of
nerve root involvement. Classification into the group with
LBP +NRI required the presence of just one positive find-
ing in the neurological examination, and the reliability of
these findings in our clinical department, notwithstanding
an ongoing quality assurance program, is unknown. A lack
of such knowledge and less stringent procedures for data
collection than are possible in clinical trials are inherent
limitations of data from large clinical databases that were
not collected for a specific research project. Moreover, for
unknown reasons, answers to sick leave questions at fol-
low-up were more often incomplete than other outcome
measures. However, this did appear to affect subgroup
differences.
Overall, this simple QTF classification of LBP displayed
an association with the outcome of activity limitation that
was above what could be explained by other measured
baseline characteristics, and the QTF subgroups were also
associated with sick leave after 3 months when only dur-
ation was included as a covariate. Subgroup differences
were most marked between Local LBP and LBP +NRI and
sometimes these groups also differed from other groups.
However, whether leg pain location was above or below
the knee was not an important distinction for the outcome
measures investigated.
Despite the QTF classification displaying statistically
significant associations at a subgroup level, it explained
very little of the variance (2%) in the outcome activity
limitation at an individual patient level and the predict-
ive ability relating to sick leave was also low when mea-
sured by the AUC statistic. It is not uncommon in LBP
that prognostic factors show statistically significant asso-
ciations with outcome at a group level but little predict-
ive value at an individual level [27] and there is no
evidence for a single factor that substantially affects LBP
prognosis on its own for all individuals. Also, investigat-
ing separate prognostic factors is a necessary step to in-
form more sophisticated modelling of multiple factors
that may be more accurate for individuals. Hayden et al.
classified prognostic research as a 3-step sequential
process [28]. Initially, factors that are associated with
outcome are identified, then tested for their independent
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investigated by mapping how prognostic factors, media-
tors and moderators interact and influence outcome.
The current study would be classified as a second step
investigation and suggests that leg pain and presence of
neurological signs should be included in studying prog-
nostic pathways.
However, another potentially important result from
prognostic research is the treatment implications of sub-
group-targeted treatment. Classification tools such as the
STarT Back Tool have shown that appropriate matching
of treatment pathways to prognostic subgroups can result
in better patient outcomes that are also cost-effective [29].
It may be that the cost-effectiveness of LBP care can be
improved by subgroup-focused treatment of patients, even
if those groups, such as QTF subgroups, are not com-
pletely homogenous. Put another way, useful improve-
ments in outcomes may result at a clinical population
level, even if the predictability of outcome in individuals
remains limited. The current study was unable to explore
this as treatment was not targeted to the QTF subgroups,
but the principle of subgroup-targeted treatment is a
promising direction for research.
Conclusion
In summary, the QTF classification was a prognostic fac-
tor at a group level but not very accurate at predicting
outcome for individual patients. Therefore this classifica-
tion should be considered as a factor to be included in
multi-factor predictive models, though probably without
the distinction of pain above and below the knee. Also, it
remains to be investigated whether the QTF classification
is a potential treatment effect modifier and its role as a
predictor and/or treatment effect modifier may qualify it
to be included in multi-dimensional subgrouping tools.
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